KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $0.87 $1.65 Friday, 26th Apr 2024 ADAP stock ended at $1.08. This is 1.42% more than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 5.83% from a day low at $1.03 to a day high of $1.09.
90 days $0.730 $2.05
52 weeks $0.420 $2.05

Historical Adaptimmune Therapeutics plc prices

Date Open High Low Close Volume
Jul 12, 2022 $1.71 $1.79 $1.66 $1.76 122 578
Jul 11, 2022 $1.84 $1.85 $1.71 $1.71 188 158
Jul 08, 2022 $1.81 $1.91 $1.81 $1.87 205 211
Jul 07, 2022 $1.73 $1.88 $1.73 $1.84 375 423
Jul 06, 2022 $1.65 $1.80 $1.65 $1.73 389 340
Jul 05, 2022 $1.60 $1.79 $1.60 $1.66 873 296
Jul 01, 2022 $1.75 $1.75 $1.61 $1.65 381 444
Jun 30, 2022 $1.71 $1.76 $1.63 $1.70 331 098
Jun 29, 2022 $1.77 $1.77 $1.68 $1.71 188 431
Jun 28, 2022 $1.70 $1.85 $1.67 $1.74 314 595
Jun 27, 2022 $1.65 $1.76 $1.61 $1.70 228 364
Jun 24, 2022 $1.72 $1.79 $1.61 $1.62 911 538
Jun 23, 2022 $1.75 $1.85 $1.66 $1.74 683 762
Jun 22, 2022 $1.72 $1.82 $1.68 $1.73 334 836
Jun 21, 2022 $1.79 $1.87 $1.66 $1.68 321 037
Jun 17, 2022 $1.58 $1.91 $1.58 $1.78 1 468 068
Jun 16, 2022 $1.55 $1.64 $1.53 $1.60 242 683
Jun 15, 2022 $1.48 $1.69 $1.48 $1.61 726 924
Jun 14, 2022 $1.53 $1.57 $1.46 $1.48 363 508
Jun 13, 2022 $1.59 $1.59 $1.44 $1.53 429 083
Jun 10, 2022 $1.62 $1.68 $1.57 $1.60 413 973
Jun 09, 2022 $1.69 $1.75 $1.65 $1.66 459 764
Jun 08, 2022 $1.60 $1.80 $1.60 $1.70 485 091
Jun 07, 2022 $1.50 $1.63 $1.44 $1.62 307 253
Jun 06, 2022 $1.71 $1.71 $1.51 $1.52 410 385
Click to get the best stock tips daily for free!

About Adaptimmune Therapeutics plc

Adaptimmune Therapeutics plc Adaptimmune Therapeutics plc, a clinical-stage biopharmaceutical company, focuses on providing novel cell therapies primarily to patients with solid tumors in the United States and the United Kingdom. The company's specific peptide enhanced affinity receptor (SPEAR) T-cell platform enables it to identify cancer targets. It is developing ADP-A2M4 that is in phase II clinical trials with SPEARHEAD-1 for synovial sarcoma and myxoid round cell liposa... ADAP Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT